Search Results
Web results
Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with ...
American Chemical Society
https://pubs.acs.org › doi
American Chemical Society
https://pubs.acs.org › doi
Sep 16, 2025 — For instance, xGLP/GCG/GIP-20, which utilizes an εLys-εLys-γGlu-20diacid side chain, exhibited superior activity compared to xGLP/GCG/GIP-21, ...Read more
Structural basis for the therapeutic advantage of dual and ...
bioRxiv
https://www.biorxiv.org › 2021.07.29.454286.full
bioRxiv
https://www.biorxiv.org › 2021.07.29.454286.full
by F Zhao2021Cited by 4 — Two residues with shorter side-chains (I7P and A13P) in GIP further weakened its binding to GLP-1R, consistent with the distinct cross- ...Read more
Gip Glp 1 Dual Agonist Side Chain
SINOPEG
https://www.sinopeg.com › gip-glp-1-dual-agonist-side-...
SINOPEG
https://www.sinopeg.com › gip-glp-1-dual-agonist-side-...
GIP / GLP-1 dual agonist Side Chain [OtBu-Ara-Glu(AEEA-AEEA-OH)-OtBu]. GIP / GLP-1 dual agonist Side Chain. Product Name ...Read more
GIP / GLP-1 dual agonist Side Chain [OtBu-Ara-Glu(AEEA- ...
Amerigo Scientific
https://www.amerigoscientific.com › gip-glp-1-dual-ag...
Amerigo Scientific
https://www.amerigoscientific.com › gip-glp-1-dual-ag...
GIP / GLP-1 dual agonist Side Chain [OtBu-Ara-Glu(AEEA-AEEA-OH)-OtBu] ; Catalog Number: FC01410330SIN ; Mfr. No.: SIN230241AM ; Price: Inquiry.Read more
$200 delivery
GLP-1 Agonists
Cleveland Clinic
https://my.clevelandclinic.org › health › treatments › 13...
Cleveland Clinic
https://my.clevelandclinic.org › health › treatments › 13...
GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity. They're often injection medications.
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide
Taylor & Francis Online
https://www.tandfonline.com › ... › Volume 16, Issue
Taylor & Francis Online
https://www.tandfonline.com › ... › Volume 16, Issue
by L Wang2023Cited by 71 — Apart from this hydrophobic region, it seems that GLP-1R prefers a carboxyl group at the end of the side chain while GIPR can accommodate, but ...Read more
Long Acting GLP-1 Receptor Agonist Drugs Lists and ...
Biopharma PEG
https://www.biochempeg.com › article
Biopharma PEG
https://www.biochempeg.com › article
Nov 11, 2021 — Fatty acid side chain: A C-18 diacid chain is attached to the C-terminus, extending the half-life to approximately 7 days and enabling once- ...Read more
Roche's Novel Dual GLP-1/GIP Receptor Agonist ...
Applied Clinical Trials
https://www.appliedclinicaltrialsonline.com › view › roch...
Applied Clinical Trials
https://www.appliedclinicaltrialsonline.com › view › roch...
May 16, 2024 — A once-weekly SC injectable, CT-388 is a dual GLP-1/GIP receptor agonist designed to produce potent activity on both the GLP-1 and GIP receptors ...Read more
Structural determinants of dual incretin receptor agonism ...
PNAS
https://www.pnas.org › doi › pnas.2116506119
PNAS
https://www.pnas.org › doi › pnas.2116506119
Mar 25, 2022 — Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R).Read more
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the ...
Springer Nature Link
https://link.springer.com › article
Springer Nature Link
https://link.springer.com › article
by MA Nauck2022Cited by 374 — Tirzepatide is the first dual GIP/GLP-1 receptor co-agonist approved for the treatment of type 2 diabetes in the USA, Europe, and the UAE.